Prolonged survival of lymphocytes with chromosomal defects in children treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
D000208:Acute Disease; D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations / Q000187:drug effects*; D046508:Culture Techniques; D005260:Female; D005266:Femoral Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D007223:Infant; D037102:Lectins / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000532:radiotherapy; D007962:Leukocytes / Q000187:drug effects / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D009603:Nitroso Compounds / Q000627:therapeutic use*; D012512:Sarcoma, Ewing / Q000188:drug therapy* / Q000532:radiotherapy; D014508:Urea
D000970:Antineoplastic Agents; D037102:Lectins; D009603:Nitroso Compounds; D014508:Urea